User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 2 results.
    • Journal article
    Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.
    Opal, Steven M Laterre, Pierre-François[UCL] Francois, Bruno LaRosa, Steven P Angus, Derek C Mira, Jean-Paul Wittebole, Xavier[UCL] Dugernier, Thierry Perrotin, Dominique Tidswell, Mark Jauregui, Luis Krell, Kenneth Pachl, Jan Takahashi, Takeshi Peckelsen, Claus Cordasco, Edward Chang, Chia-Sheng Oeyen, Sandra Aikawa, Naoki Maruyama, Tatsuya Schein, Roland Kalil, Andre C Van Nuffelen, Marc Lynn, Melvyn Rossignol, Daniel P Gogate, Jogadish Roberts, Mary B Wheeler, Janice L Vincent, Jean-Louis ACCESS Study Group. (2013) JAMA : the journal of the American Medical Association — Vol. 309, no.11, p. 1154 [1-9] (2013)
    • Journal article
    Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis: A Randomized Controlled Trial
    OPTIMIST Trial Study Group Abraham, Edward Reinhart, Konrad Opal, Steven Demeyer, Ignace Doig, Christopher López Rodriguez, Angel Beale, Richard Svoboda, Petr Laterre, Pierre-François[UCL] Simon, Stuart Light, Bruce Spapen, Herbert Stone, Judy Seibert, Allan Peckelsen, Claus De Deyne, Cathy Postier, Russell Pettilä, Ville Sprung, Charles L. Artigas, Antonio Percell, Sandra R. Shu, Vincent Zwingelstein, Christian Tobias, Jeffrey Poole, Lona Stolzenbach, James C. Creasey, Abla A. (2003) JAMA : the journal of the American Medical Association — Vol. 290, no. 2, p. 238-247 (2003)